BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Liver
,
Alcohol
,
Aspirin
,
rs2300478
,
FOXP1
,
glucose metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Lysis
Summary
General Info
Curated Studies
Most Correlated Studies
Neutrophils treated with hospital-, community-associated S. aureus or latex beads
Th effector-memory cells after various isolation methods and storage conditions
T cells (gamma-delta) response to Plasmodium falciparum infected red blood cells
Follicular (FO) and marginal zone (MZ) B cell miRNA expression in Dicer mutants
Prostate adenocarcinoma LNCaP cells treated with celastrol
Explore Curated Studies Results
Literature
Most Relevant Literature
Association of the metabolic syndrome with PAI 1act and clot lysis time over a 10-year follow up in …
Impaired fibrin clot lysis is associated with increased mortality in patients after coronary artery …
Serum phosphate level and its kinetic as an early marker of acute kidney injury in tumor lysis syndr…
Tumor lysis syndrome after the administration of corticosteroids in an adolescent without confirmed …
Tumor lysis syndrome following ifosfamide monotherapy in metastatic osteosarcoma: a case report and …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Maternal Outcomes Following Manual Lysis of the Placenta.
Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome
Rasburicase in Patients at Risk for Tumor Lysis Syndrome
Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies
A Study on Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive B-Lymphoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ